Safety and Efficacy ATYR1923, a Novel Immunomodulator for Pulmonary Sarcoidosis: Results of a Phase 1b/2a Randomized Placebo-Controlled Trial
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2022）
Key words
pulmonary sarcoidosis,efficacy atyr1923,novel immunomodulator,placebo-controlled
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined